This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Lihysyng Stanford Lee: Innovator in Protein Conjugates
Introduction
Lihysyng Stanford Lee is a notable inventor based in the United States. He has made significant contributions to the field of biotechnology, particularly in the development of novel protein conjugates. His work focuses on enhancing the efficacy and stability of therapeutic proteins.
Latest Patents
Lihysyng Stanford Lee holds a patent for "Polyethylene Glycol Erythropoietin Conjugates." This invention relates to novel pegylated proteins and their methods of making and use. One aspect of this invention is the pegylated-erythropoietin, which demonstrates greater clinical efficacy and stability during shipment and storage compared to current erythropoietin formulations. Although he has 0 patents, his contributions are noteworthy in the realm of protein conjugation.
Career Highlights
Lihysyng Stanford Lee is currently associated with Prolong Pharmaceuticals, LLC. His role at the company allows him to further his research and development efforts in the field of biotechnology. His innovative approach to protein conjugates has the potential to impact therapeutic applications significantly.
Collaborations
Lihysyng has collaborated with Abraham Abuchowski, a fellow innovator in the field. Their partnership has likely contributed to advancements in the development of pegylated proteins.
Conclusion
Lihysyng Stanford Lee is a prominent figure in the biotechnology sector, known for his innovative work on pegylated proteins. His contributions, particularly in the area of erythropoietin conjugates, highlight the importance of innovation in improving therapeutic efficacy and stability.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile